Analysis of arterial intimal hyperplasia: Review and hypothesis

Theoretical Biology and Medical Modelling

Volumn 4, Issue , 2007, Pages

  Subbotin, Vladimir M ^a  

^a Mirus Bio Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; HUMAN; HYPERPLASIA; HYPOTHESIS; MEDICAL EDUCATION; MICROSCOPY; PERCEPTRON; PHENOTYPE; POPULATION; VASCULARIZATION; ANIMAL; ARTERY; CHRONIC DISEASE; CORONARY ARTERY DISEASE; GRAFT REJECTION; INTIMA; PATHOLOGY; REVIEW; TRANSPLANTATION;

EUTHERIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; ARTERIES; CHRONIC DISEASE; CORONARY ARTERY DISEASE; GRAFT REJECTION; HUMANS; HYPERPLASIA; TRANSPLANTS; TUNICA INTIMA;

EID: 37649016733     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-4-41     Document Type: Article

References (291)

1. Waging war on modern chronic diseases: primary prevention through exercise biology. FW Booth SE Gordon CJ Carlson MT Hamilton, J Appl Physiol 2000 88 774 787 10658050
2. Optimal medical therapy with or without PCI for stable coronary disease. WE Boden RA O'Rourke KK Teo PM Hartigan DJ Maron WJ Kostuk M Knudtson M Dada P Casperson CL Harris, N Engl J Med 2007 356 1503 1516 10.1056/NEJMoa070829 17387127
3. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. FW Booth MV Chakravarthy SE Gordon EE Spangenburg, J Appl Physiol 2002 93 3 30 12070181
4. Exercise Controls Gene Expression. FW Booth PD Neufer, American Scientist 2005 93
5. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. JA Iestra D Kromhout YT van der Schouw DE Grobbee HC Boshuizen WA van Staveren, Circulation 2005 112 924 934 10.1161/CIRCULATIONAHA.104.503995 16087812
6. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. HC Stary DH Blankenhorn AB Chandler S Glagov W Insull Jr M Richardson ME Rosenfeld SA Schaffer CJ Schwartz WD Wagner, Arterioscler Thromb 1992 12 120 134 1731855
7. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. HC Stary AB Chandler RE Dinsmore V Fuster S Glagov W Insull Jr ME Rosenfeld CJ Schwartz WD Wagner RW Wissler, Circulation 1995 92 1355 1374 7648691
8. The risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators. A Cano C Hermenegildo P Oviedo JJ Tarin, Front Biosci 2007 12 49 68 10.2741/2048 17127283
9. Coronary disease in the young. Dissertation. WD Shapiro, University of Wisconsin, Medicine 1951
10. A definition of the intima of human arteries and of its atherosclerosis- prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. HC Stary DH Blankenhorn AB Chandler S Glagov WJ Insull M Richardson ME Rosenfeld SA Schaffer CJ Schwartz WD Wagner, Circulation 1992 85 391 405 1728483
11. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. HC Stary AB Chandler RE Dinsmore V Fuster S Glagov W Insull Jr ME Rosenfeld CJ Schwartz WD Wagner RW Wissler, Arterioscler Thromb Vasc Biol 1995 15 1512 1531 7670967
12. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. A Desmouliere IA Darby G Gabbiani, Lab Invest 2003 83 1689 1707 10.1097/01.LAB.0000101911.53973.90 14691287
13. The myofibroblast: a quarter century after its discovery. W Schurch TA Seemayer G Gabbiani, Am J Surg Pathol 1998 22 141 147 10.1097/00000478- 199802000-00001 9500214
14. SF Gilbert, Developmental Biology Sunderland: Sinauer Associates, Inc 4 1994
15. P Chandrasoma CR Taylor, Concise pathology Norwalk: Appleton & Lange 2 1995
16. Preatheroma Phase of Coronary Atherosclerosis in Man. A Daoud J Jarmolych A Zumbo Fani R Florentin, Exp Mol Pathol 1964 90 475 484 10.1016/0014-4800(64) 90028-0 14225066
17. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? ML Bots D Baldassarre A Simon E de Groot DH O'Leary W Riley JJ Kastelein DE Grobbee, Eur Heart J 2007 28 398 406 10.1093/eurheartj/ehl482 17277033
18. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. MJ Hung WJ Cherng NI Yang CW Cheng LF Li, Am J Cardiol 2005 96 1484 1490 10.1016/j.amjcard.2005.07.055 16310426
19. Diffuse intimal thickening of coronary arteries in slow coronary flow. VG Cin H Pekdemir A Camsar D Cicek MN Akkus T Parmaksyz T Katyrcybay O Doven, Jpn Heart J 2003 44 907 919 10.1536/jhj.44.907 14711186
20. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. Y Miyao K Kugiyama H Kawano T Motoyama H Ogawa M Yoshimura T Sakamoto H Yasue, J Am Coll Cardiol 2000 36 432 437 10.1016/S0735-1097(00)00729- 4 10933354
21. Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction. H Luo T Nishioka NL Eigler JS Forrester MC Fishbein H Berglund RJ Siegel, Arterioscler Thromb Vasc Biol 1996 16 1393 1398 8911279
22. Coronary atherosclerosis and interventions: pathological sequences and restenosis. C Yutani M Imakita H Ishibashi-Ueda Y Tsukamoto N Nishida Y Ikeda, Pathol Int 1999 49 273 290 10.1046/j.1440-1827.1999.00861.x 10365846
23. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. N Kipshidze G Dangas M Tsapenko J Moses MB Leon M Kutryk P Serruys, J Am Coll Cardiol 2004 44 733 739 15312851
24. Intracoronary brachytherapy - clinical state and pathophysiological considerations. F Krotz HY Sohn V Klauss TM Schiele, Curr Pharm Des 2005 11 421 433 10.2174/1381612053382025 15725063
25. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization. R Sheppard MJ Eisenberg D Donath D Meerkin, Am Heart J 2003 146 775 786 10.1016/S0002-8703(03)00389-2 14597925
26. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy. P Teirstein JP Reilly, J Invasive Cardiol 2002 14 109 114 11870263
27. Vascular restenosis - striving for therapy. TM Schiele F Krotz V Klauss, Expert Opin Pharmacother 2004 5 2221 2232 10.1517/14656566.5.11.2221 15500368
28. Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. GL Kaluza AE Raizner, Curr Opin Cardiol 2004 19 601 607 10.1097/01.hco.0000142069.39957.03 15502506
29. Molecular basis of restenosis and drug-eluting stents. MA Costa DI Simon, Circulation 2005 111 2257 2273 10.1161/01.CIR.0000163587.36485.A7 15867193
30. Vascular radiation in a drug-eluting stent world: it's not over till it's over. PS Teirstein S King, Circulation 2003 108 384 385 10.1161/01.CIR. 0000080229.68147.4F 12885730
31. Persistence of neointimal growth 12 months after intervention and occurrence of delayed restenosis in patients with left main coronary artery disease treated with drug-eluting stents. M Valgimigli P Malagutti CA van Mieghem S Vaina JM Ligthart G Sianos PW Serruys, J Am Coll Cardiol 2006 47 1491 1494 10.1016/j.jacc.2006.01.008 16580544
32. Intimal Hyperplasia: The Clinical problem. AD Callow, Intimal Hyperplasia Austin: R.G. Landes Co, Dobrin PB, 1994 3 12 [Medical intelligence unit]
33. Irradiation for the treatment of intimal hyperplasia. JE Fortunato S Glagov HS Bassiouny, Ann Vasc Surg 1998 12 495 503 10.1007/s100169900191 9732431
34. Rapamycin eluting stent: the onset of a new era in interventional cardiology. PW Serruys E Regar AJ Carter, Heart 2002 87 305 307 11906992 10.1136/heart.87.4.305
35. Prevention of coronary restenosis with radiation therapy: a review. N Hafeez, Clin Cardiol 2002 25 313 322 10.1002/clc.4950250703 12109864
36. Early invasive versus selectively invasive management for acute coronary syndromes. RJ de Winter F Windhausen JH Cornel PH Dunselman CL Janus PE Bendermacher HR Michels GT Sanders JG Tijssen FW Verheugt, N Engl J Med 2005 353 1095 1104 10.1056/NEJMoa044259 16162880
37. Coronary intervention for persistent occlusion after myocardial infarction. JS Hochman GA Lamas CE Buller V Dzavik HR Reynolds SJ Abramsky S Forman W Ruzyllo AP Maggioni H White, N Engl J Med 2006 355 2395 2407 17105759 10.1056/NEJMoa066139
38. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. DG Katritsis JP Ioannidis, Circulation 2005 111 2906 2912 10.1161/CIRCULATIONAHA.104.521864 15927966
39. Choosing a future for epidemiology: I. Eras and paradigms. M Susser E Susser, Am J Public Health 1996 86 668 673 8629717
40. The role of methods in maintaining orthodox beliefs in health research. K Dean, Soc Sci Med 2004 58 675 685 10.1016/S0277-9536(03)00219-3 14672584
41. Beyond the orthodox: heresy in medicine and social science. G Gillett, Soc Sci Med 1994 39 1125 1131 10.1016/0277-9536(94)90345-X 7801150
42. Redundant publications in scientific ophthalmologic journals: the tip of the iceberg? SM Mojon-Azzi X Jiang U Wagner DS Mojon, Ophthalmology 2004 111 863 866 10.1016/j.ophtha.2003.09.029 15121360
43. Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? RA Armstrong NJ Cairns PL Lantos, Neuropathology 2002 22 133 146 10.1046/j.1440-1789.2002.00446.x 12416552
44. C-reactive protein increase in unstable coronary disease cause or effect? S De Servi M Mariani G Mariani A Mazzone, J Am Coll Cardiol 2005 46 1496 1502 10.1016/j.jacc.2005.05.083 16226174
45. Aspects of scientific discourse: Conditional argumentation. M Horsella G Sindermann, English for Specific Purposes 1992 11 129 139 10.1016/S0889-4906(05) 80004-3
46. Seven fundamental, unsolved questions in molecular biology. Cooperative storage and bi-directional transfer of biological information by nucleic acids and proteins: an alternative to "central dogma". JC Biro, Med Hypotheses 2004 63 951 962 10.1016/j.mehy.2004.06.024 15504561
47. Transplant vasculopathy: a model for coronary artery disease? MC Deng G Plenz M Erren MJ Wilhelm G Moennig M Rothenburger HA Baba, Herz 2000 25 95 99 10.1007/PL00001959 10829247
48. Dendritic cells in neointima formation: from where did you come, and what are you doing here? T Takahashi RT Lee, J Am Coll Cardiol 2003 42 939 941 10.1016/S0735-1097(03)00840-4 12957446
49. T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty. M Osada S Takeda R Ogawa S Komori K Tamura, J Interferon Cytokine Res 2001 21 219 221 10.1089/107999001750169835 11359652
50. Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair. G Bauriedel A Jabs D Skowasch R Hutter JJ Badimon V Fuster U Welsch B Luderitz, J Am Coll Cardiol 2003 42 930 938 10.1016/S0735-1097(03)00828-3 12957445
51. Boom or bubble? Is medical research thriving or about to crash? BG Charlton, Med Hypotheses 2006 66 1 2 10.1016/j.mehy.2005.10.004 16242249
52. Medical research funding may have over-expanded and be due for collapse. BG Charlton P Andras, Qjm 2005 98 53 55 10.1093/qjmed/hci003 15625354
53. Ueber die Abhängigkeit der Bindegewebsneubildung in der Arterienintima von den mechanischen Bedingungen des Blutumlaufes. Erste Mittheilung. Die Rückwirkung des Verschlusses der Nabelarterien und des arteriösen Ganges auf die Structur der Aortenwand. R Thoma, Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin (Virchows Archiv) 1883 93 443 505 10.1007/BF02324120
54. Über die Intima der Arterien. R Thoma, Virchows Archiv 1921 230 1 45 10.1007/BF01948742
55. Über die histologische Struktur der Coronararterien des menschlichen Herzens. K Wolkoff, Virchows Archiv 1923 241 42 58 10.1007/BF01942462
56. Arteriosclerosis in Low Mammals and Birds; Its Relation to the Disease in Man. H Fox, Arteriosclerosis; a survey of the problem New York: The Macmillan Company, Cowdry EV, 1933 153 194
57. Atherosclerosis in rat kangaroos. BC Ward JN Shively, Arch Pathol 1974 98 90 93 4366207
58. Coronary arteries in infants up to the age of ten years. I. Chronology of adaptive intimal changes. C Velican D Velican, Rev Roum Med Intern 1975 13 19 24 1215799
59. Coronary arteries in children up to the age of ten years II. Intimal thickening and its role in atherosclerotic involvement. C Velican D Velican, Med Interne 1976 14 17 24 946692
60. Particular aspects of the children coronary artery remodelling. C Velican D Velican, Med Interne 1978 16 127 134 663532
61. Some particular aspects of the microarchitecture of human coronary arteries. C Velican D Velican, Atherosclerosis 1979 33 191 200 10.1016/0021-9150(79)90116-3 475878
62. Arteriosclerosis in exotic mammals. F Bohorquez C Stout, Atherosclerosis 1972 16 225 231 10.1016/0021-9150(72)90056-1 4634814
63. The fine structure of the mammalian arterial wall. A Bálint, Arterial lesion and arteriosclerosis London-New York: Plenium Press, Jellinek H, 1974
64. Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. JE French, Int Rev Exp Pathol 1966 5 253 353 4877347
65. Coronary intimal thickenings and lipids in Finnish children who died violently. J Hirvonen S Yla-Herttuala H Laaksonen M Mottonen T Nikkari E Pesonen J Raekallio HK Akerblom, Acta Paediatr Scand Suppl 1985 318 221 224 3867229
66. Atherogenesis and the coronary arteries of childhood. H Davies, Int J Cardiol 1990 28 283 291 10.1016/0167-5273(90)90310-2 2210892
67. The intima of human coronary arteries. FH Sims JB Gavin MA Vanderwee, Am Heart J 1989 118 32 38 10.1016/0002-8703(89)90068-9 2741794
68. Improving vascular grafts: the importance of mechanical and haemodynamic properties. SE Greenwald CL Berry, J Pathol 2000 190 292 299 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S 10685063
69. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. ER O'Brien KL Bennett MR Garvin TW Zderic T Hinohara JB Simpson T Kimura M Nobuyoshi H Mizgala A Purchio SM Schwartz, Arterioscler Thromb Vasc Biol 1996 16 576 584 8624780
70. Arterial expression of the plasminogen activator system early after cardiac transplantation. MR Garvin M Labinaz K Pels VM Walley HF Mizgala ER O'Brien, Cardiovasc Res 1997 35 241 249 10.1016/S0008-6363(97)00088-6 9349387
71. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens. H Miller S Poon B Hibbert K Rayner YX Chen ER O'Brien, Arterioscler Thromb Vasc Biol 2005 25 e10 14 10.1161/01.ATV.0000156536.89752.8e 15662019
72. Neonatal intima formation in the human coronary artery. Y Ikari BM McManus J Kenyon SM Schwartz, Arterioscler Thromb Vasc Biol 1999 19 2036 2040 10479643
73. Hyperplasia of coronary intima in young males in relation to development of coronary heart disease in adults. VS Zhdanov NH Sternby IP Drobkova IE Galakhov, Int J Cardiol 2000 76 57 64 10.1016/S0167-5273(00)00369-7 11121597
74. Intimal preatherosclerotic thickening of the coronary arteries in human fetuses of smoker mothers. L Matturri AM Lavezzi G Ottaviani L Rossi, J Thromb Haemost 2003 1 2234 2238 10.1046/j.1538-7836.2003.00409.x 14521609
75. Arteriosklerose der Coronararterien des Herzens. NJ Kusnetzowsky, Virchows Archiv 1923 245 55 77 10.1007/BF01992098
76. Normal and oxidized low density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries. M Fukuchi J Watanabe K Kumagai S Baba T Shinozaki M Miura Y Kagaya K Shirato, Lab Invest 2002 82 1437 1447 12379778
77. Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age. Y Nakashima YX Chen N Kinukawa K Sueishi, Virchows Arch 2002 441 279 288 10.1007/s00428-002-0605-1 12242525
78. Morphometric and immunohistochemical characterization of the intimal layer throughout the arterial system of elderly humans. A Vink AH Schoneveld M Poppen DP de Kleijn C Borst G Pasterkamp, J Anat 2002 200 97 103 11837253 10.1046/j.0021-8782.2001.00005.x
79. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. W Rosamond K Flegal G Friday K Furie A Go K Greenlund N Haase M Ho V Howard B Kissela, Circulation 2007 115 e69 171 10.1161/CIRCULATIONAHA.106. 179918 17194875
80. The 2002 European registry of cardiac catheter interventions. W Maier M Abay S Cook M Togni A Zeiher B Meier, Int J Cardiol 2006 113 299 304 10.1016/j.ijcard.2005.11.026 16371236
81. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. R Cooper J Cutler P Desvigne-Nickens SP Fortmann L Friedman R Havlik G Hogelin J Marler P McGovern G Morosco, Circulation 2000 102 3137 3147 11120707
82. KS Thomson, Morphogenesis and evolution New York: Oxford University Press 1988
83. GR Osborn, The incubation period of coronary thrombosis London: Butterworths 1963
84. LC Junqueira J Carneiro, Basic Histology : Text & Atlas. 11th International Edition edn The McGraw-Hill Companies 2005
85. AW Ham, Histology Philadelphia: Lippincott 9 1987
86. HD Dellmann, Textbook of Veterinary Histology Lippincott Williams & Wilkins 1998
87. Endothelial and Smooth-Muscle Cells. I Huttner O Kocher G Gabbani, Diseases of the arterial wall London: Springer-Verlag, Camilleri J-P, Berry CL, Fiessinger J-N, Bariety J, 1989 3 41
88. M Friedman, Pathogenesis of coronary artery disease New York: Blakiston Division, McGraw-Hill 1969
89. Vascular Endothelium. PE DiCorleto MAJ Gimbrone, Atherosclerosis and coronary artery disease Philadelphia: Lippincott-Raven, Fuster V, Ross R, Topol EJ, 1 1996 387 399
90. The endothelium: injury and repair of the arterial wall. ID Goldberg, The Coronary Artery New York: Oxford University Press, Kalsner S, 1982 417 432
91. W Kuehnel, Color Atlas of Cytology, Histology, and Microscopic Anatomy New York: Thieme Verlag 4 2003
92. RL Bacon NR Niles, Medical histology : a text-atlas with introductory pathology New York: Springer-Verlag 1983
93. MH Ross GI Kaye W Pawlina, Histology : a text and atlas Philadelphia: Lippincott Williams & Wilkins 4 2003
94. 11. Circulatory System. LP Gartner JL Hiatt, Color textbook of histology Philadelphia: Saunders/Elsevier 3 2007 251 271
95. Histology for Pathologists Philadelphia Lippincott-Raven 2 1997
96. Blood Vessels. Chapter 33. PJ Gallagher, Histology for Pathologists Philadelphia: Lippincott-Raven, Sternberg SS, 2 1997 763 786
97. General features, structures, topography and adaptation of the circulatory systems. WE Stehbens, Vascular pathology London: Chapman & Hall Medical, Stehbens WE, Lie JT, 1995 1 20
98. A critical examination of animal models of restenosis following angioplasty. ER O'Brien D deBlois SM Schwartz, Intimal Hyperplasia Austin: R.G. Landes Co, Dobrin PB, 1994 229 256 [Medical intelligence unit]
99. The intima. Soil for atherosclerosis and restenosis. SM Schwartz D deBlois ER O'Brien, Circ Res 1995 77 445 465 7641318
100. PB Dobrin, Intimal hyperplasia Austin: R.G. Landes Co 1994
101. Pathology of chronic rejection: an overview of common findings and observations about pathogenic mechanisms and possible prevention. AJ Demetris N Murase TE Starzl JJ Fung, Graft 1998 I 52 59
102. Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection. JG Geraghty RL Stoltenberg HW Sollinger DA Hullett, Transplantation 1996 62 502 509 10.1097/00007890-199608270-00013 8781617
103. Arteriopathy in chronic allograft rejection in liver transplantation. A Miyagawa-Hayashino T Tsuruyama H Haga F Oike K Il-Deok H Egawa H Hiai K Tanaka T Manabe, Liver Transpl 2004 10 513 519 10.1002/lt.20081 15048794
104. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. S Oguma S Belle TE Starzl AJ Demetris, Hepatology 1989 9 204 209 10.1002/hep.1840090207 2643544
105. Diagnosis of chronic lung transplant rejection by transbronchial biopsy. PT Cagle RW Brown A Frost C Kellar SA Yousem, Mod Pathol 1995 8 137 142 7777473
106. Participation of dendritic cells in vascular lesions of chronic rejection of human allografts. S Oguma B Banner T Zerbe T Starzl AJ Demetris, Lancet 1988 2 933 936 10.1016/S0140-6736(88)92600-1 2902383
107. Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. MC Deng S Bell P Huie F Pinto SA Hunt EB Stinson R Sibley BM Hall HA Valantine, Circulation 1995 91 1647 1654 7882470
108. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. R Ciubotariu Z Liu AI Colovai E Ho S Itescu S Ravalli MA Hardy R Cortesini EA Rose N Suciu-Foca, J Clin Invest 1998 101 398 405 9435312
109. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. PI Hornick PD Mason RJ Baker M Hernandez-Fuentes L Frasca G Lombardi K Taylor L Weng ML Rose MH Yacoub, Circulation 2000 101 2405 2410 10821818
110. Acute and chronic rejection. A Tejani L Emmett, Semin Nephrol 2001 21 498 507 10.1053/snep.2001.24945 11559891
111. Recent advances in the immunology of chronic rejection. JS Allan JC Madsen, Curr Opin Nephrol Hypertens 2002 11 315 321 10.1097/00041552-200205000- 00008 11981262
112. Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides. H Shirwan A Mhoyan TP Kakoulidis ES Yolcu S Ibrahim, Am J Transplant 2003 3 581 589 10.1034/j.1600-6143.2003.00052.x 12752314
113. Activation of autoimmune B cells and chronic rejection. ML Rose, Transplantation 2005 79 S22 24 10.1097/01.TP.0000153294.38939.5F 15699740
114. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. P Libby H Tanaka, Clin Transplant 1994 8 313 318 7520306
115. Immune-vascular interaction in atherosclerosis and transplant arteriosclerosis. GK Hansson, Transplant Vascular Scerosis Ohio: R. G. Landes Company, Orosz CG, Sedmak DD, Ferguson RM, 1995 71 81
116. Cardiac allograft vasculopathy after cardiac transplantation and hormone therapy: positive effects? V Lange A Renner M Sagstetter H Harms O Elert, Transplantation 2006 82 234 240 10.1097/01.tp.0000226179.16065.5e 16858287
117. Mortality after kidney transplant failure: the impact of non-immunologic factors. JS Gill R Abichandani AT Kausz BJ Pereira, Kidney Int 2002 62 1875 1883 10.1046/j.1523-1755.2002.00640.x 12371992
118. Chronic rejection and its risk factors. NL Tilney, Transplant Proc 1999 31 41S 44S 10.1016/S0041-1345(98)02080-6 10078226
119. Effects of cytomegalovirus infection and prolonged cold ischemia on chronic rejection of rat renal allografts. JG van Dam F Li M Yin XM You G Grauls G Steinhoff CA Bruggeman, Transpl Int 2000 13 54 63 10.1007/s001470050009 10743691
120. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. A Mennander S Tiisala J Halttunen S Yilmaz T Paavonen P Hayry, Arterioscler Thromb 1991 11 671 680 2029505
121. Development of a mouse aortic transplant model of chronic rejection. J Koulack VC McAlister CA Giacomantonio H Bitter-Suermann AS MacDonald TD Lee, Microsurgery 1995 16 110 113 10.1002/micr.1920160213 7783601
122. Improved surgical technique for the establishment of a murine model of aortic transplantation. H Sun LA Valdivia V Subbotin A Aitouche JJ Fung TE Starzl AS Rao, Microsurgery 1998 18 368 371 10.1002/(SICI)1098-2752(1998)18: 6<368::AID-MICR5>3.0.CO;2-F 9846999
123. Vascular remodeling in transplant vasculopathy. RN Mitchell P Libby, Circ Res 2007 100 967 978 10.1161/01.RES.0000261982.76892.09 17431198
124. Antibody and complement in transplant vasculopathy. J Wehner CN Morrell T Reynolds ER Rodriguez WM Baldwin 3rd, Circ Res 2007 100 191 203 10.1161/01.RES.0000255032.33661.88 17272820
125. Impact of nonpenetrating clips on intimal hyperplasia of vascular anastomoses. SS Berman WM Kirsch YH Zhu L Anton Y Chai, Cardiovasc Surg 2001 9 540 547 10.1016/S0967-2109(01)00090-4 11604335
126. Distal Anastomotic Intimal Hyperplasia: Histocytomorphology, Pathophysiology, Etiology, and Prevention. VS Sottiurai, Int J Angiol 1999 8 1 10 10.1007/BF01616834 9826399
127. Can intimal hyperplasia and distal anastomotic intimal hyperplasia be controlled and prevented? VS Sottiurai, Ann Vasc Surg 2007 21 289 291 17484962
128. Distal anastomotic intimal hyperplasia: biogenesis and etiology. VS Sottiurai SL Sue EL Feinberg 2nd WL Bringaze AT Tran RC Batson, Eur J Vasc Surg 1988 2 245 256 10.1016/S0950-821X(88)80034-3 3215322
129. Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. M Hosono M Ueda S Suehiro Y Sasaki T Shibata K Hattori H Kinoshita, J Thorac Cardiovasc Surg 2000 120 319 328 10.1067/mtc.2000.106328 10917949
130. Neo-intimal hyperplasia in vascular grafts and its implications for autologous arterial grafting. C Purcell M Tennant J McGeachie, Ann R Coll Surg Engl 1997 79 164 168 9196335
131. Vascular tissue adaptations in end-to-end autologous arterial grafts in rats: a morphometric analysis. C Purcell M Tennant J McGeachie, J Anat 1998 192 Pt 1 37 43 9568559 10.1046/j.1469-7580.1998.19210037.x
132. B Russell, The History of Western Philosophy New York: Simon and Schuster. Inc 1972
133. History of clinical transplantation. TE Starzl, World J Surg 2000 24 759 782 10.1007/s002680010124 10833242
134. Transplantation 50 years later - progress, challenges, and promises. MH Sayegh CB Carpenter, N Engl J Med 2004 351 2761 2766 10.1056/NEJMon043418 15616214
135. New strategies for the treatment of chronic rejection. R Hoerbelt A Muniappan JC Madsen JS Allan, Curr Opin Investig Drugs 2004 5 489 498 15202721
136. Chronic rejection: failure of immune regulation. J Goodman T Mohanakumar, Front Biosci 2003 8 s838 844 10.2741/1163 12957866
137. http://www.webster.com/
138. Cardiac Allograft Vasculopathy: Real or a Normal Morphologic Variant? S Houser A Muniappan J Allan D Sachs J Madsen, The Journal of Heart and Lung Transplantation 2007 26 167 173 10.1016/j.healun.2006.11.012
139. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. R Khan A Agrotis A Bobik, Cardiovasc Res 2007 74 223 234 10.1016/j.cardiores.2007.02.012 17349984
140. Ueber die Abhangigkeit der Bindegewebsneubildung in der Arterienintima von den mechanischen Bedingungen des Blutumlaufes. R Thoma, Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin (Virchows Archiv) 1886 105 1 28 10.1007/BF01925196
141. The neglected coronary atherosclerosis. C Velican D Velican, Atherosclerosis 1983 47 215 229 10.1016/0021-9150(83)90053-9 6882496
142. Progression of coronary atherosclerosis from adolescents to mature adults. C Velican D Velican, Atherosclerosis 1983 47 131 144 10.1016/0021-9150(83)90150-8 6870996
143. Study of coronary intimal thickening. C Velican D Velican, Atherosclerosis 1985 56 331 344 10.1016/0021-9150(85)90008-5 4052151
144. Coronary atherosclerosis: where are we now? C Velican D Velican, Med Interne 1988 26 5 13 3041551
145. Intimal thickening and atherosclerotic involvement of the left main coronary artery. C Velican D Velican I Tancu, Med Interne 1985 23 95 101 4023589
146. A light microscopic study on coronary atherosclerosis in an unselected population sample of Bucharest aged 41-50 years. D Velican C Petrescu C Velican, Med Interne 1983 21 161 167 6665488
147. Prevalence of the "normal" aspect of the coronary arteries in an unselected population sample of Bucharest aged 1-60 years. D Velican C Petrescu C Velican, Med Interne 1987 25 113 119 3616436
148. Atherosclerotic involvement of the coronary arteries of adolescents and young adults. D Velican C Velican, Atherosclerosis 1980 36 449 460 10.1016/0021-9150(80)90238-5 7417364
149. Coronary anatomy and microarchitecture as related to coronary atherosclerotic involvement. D Velican C Velican, Med Interne 1989 27 257 262 2617080
150. Maladies de la paroi arterielle Paris: Flammarion 1987
151. Organogenesis of the arterial wall. CL Berry, Diseases of the arterial wall London-New York: Springer-Verlag, Camilleri J-P, Berry CL, Fiessinger J-N, Bariety J, 1989 56 70
152. Arteriosclerosis; a survey of the problem New York: The Macmillan Company 1 1933
153. Experimental arteriosclerosis in animals. N Anitschkow, Arteriosclerosis; a survey of the problem New York: The Macmillan Company, Cowdry EV, 1933 271 322
154. Über die experimentelle Atherosklerose der Herzklappen. N Anitschkow, Virchows Archiv 1915 220 233 256 10.1007/BF01949104
155. Zur Étiologie der Atherosklerose. N Anitschkow, Virchows Archiv 1924 249 73 82 10.1007/BF01891331
156. Cardiology's 10 greatest discoveries of the 20th century. NJ Mehta IA Khan, Tex Heart Inst J 2002 29 164 171 12224718
157. M Friedman GW Friedland, Medicine's 10 greatest discoveries New Haven: Yale University Press 1998
158. Personal communication. M Subotin, 2007
159. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. PF Davies CF Dewey Jr SR Bussolari EJ Gordon MA Gimbrone Jr, J Clin Invest 1984 73 1121 1129 6707208
160. Relation of structure to function in arterial walls. S Glagov, Artery 1979 5 295 304 262159
161. Wall shear stress and strain modulate experimental aneurysm cellularity. K Hoshina E Sho M Sho TK Nakahashi RL Dalman, J Vasc Surg 2003 37 1067 1074 12756356
162. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. DE Ingber J Folkman, J Cell Biol 1989 109 317 330 10.1083/jcb.109.1.317 2473081
163. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. BL Langille F O'Donnell, Science 1986 231 405 407 10.1126/science.3941904 3941904
164. Increase in endothelial cell density before artery enlargement in flow-loaded canine carotid artery. H Masuda K Kawamura K Tohda T Shozawa M Sageshima A Kamiya, Arteriosclerosis 1989 9 812 823 2590062
165. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. SP Olesen DE Clapham PF Davies, Nature 1988 331 168 170 10.1038/331168a0 2448637
166. High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor. E Sho M Komatsu M Sho H Nanjo TM Singh C Xu H Masuda CK Zarins, Exp Mol Pathol 2003 75 1 11 10.1016/S0014-4800(03)00032-7 12834620
167. Arterial enlargement, tortuosity, and intimal thickening in response to sequential exposure to high and low wall shear stress. E Sho H Nanjo M Sho M Kobayashi M Komatsu K Kawamura C Xu CK Zarins H Masuda, J Vasc Surg 2004 39 601 612 10.1016/j.jvs.2003.10.058 14981455
168. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. E Sho M Sho TM Singh H Nanjo M Komatsu C Xu H Masuda CK Zarins, Exp Mol Pathol 2002 73 142 153 10.1006/exmp.2002.2457 12231217
169. Blood flow decrease induces apoptosis of endothelial cells in previously dilated arteries resulting from chronic high blood flow. E Sho M Sho TM Singh C Xu CK Zarins H Masuda, Arterioscler Thromb Vasc Biol 2001 21 1139 1145 10.1161/hq0701.092118 11451742
170. Subnormal shear stress-induced intimal thickening requires medial smooth muscle cell proliferation and migration. M Sho E Sho TM Singh M Komatsu A Sugita C Xu H Nanjo CK Zarins H Masuda, Exp Mol Pathol 2002 72 150 160 10.1006/exmp.2002.2426 11890724
171. A lamellar unit of aortic medial structure and function in mammals. H Wolinsky S Glagov, Circ Res 1967 20 99 111 4959753
172. Molecular mechanisms of aortic wall remodeling in response to hypertension. C Xu S Lee TM Singh E Sho X Li M Sho H Masuda CK Zarins, J Vasc Surg 2001 33 570 578 10.1067/mva.2001.112231 11241129
173. Normalization of high-flow or removal of flow cannot stop high-flow induced endothelial proliferation. M Yamauchi M Takahashi M Kobayashi E Sho H Nanjo K Kawamura H Masuda, Biomed Res 2005 26 21 28 10.2220/biomedres.26.21 15806980
174. Flow patterns at the major T-junctions of the dog descending aorta. T Karino M Motomiya HL Goldsmith, J Biomech 1990 23 537 548 10.1016/0021-9290(90) 90047-7 2341417
175. Flow patterns in vessels of simple and complex geometries. T Karino HL Goldsmith M Motomiya S Mabuchi Y Sohara, Ann N Y Acad Sci 1987 516 422 441 10.1111/j.1749-6632.1987.tb33063.x 3439740
176. Disturbances of flow through transparent dog aortic arch. T Fukushima T Karino HL Goldsmith, Heart Vessels 1985 1 24 28 10.1007/BF02066483 4093352
177. Particle flow behavior in models of branching vessels. II. Effects of branching angle and diameter ratio on flow patterns. T Karino HL Goldsmith, Biorheology 1985 22 87 104 3986324
178. Disturbed flow in models of branching vessels. T Karino HL Goldsmith, Trans Am Soc Artif Intern Organs 1980 26 500 506 7245540
179. Particle flow behaviour in models of branching vessels: I. Vortices in 90 degrees T-junctions. T Karino HH Kwong HL Goldsmith, Biorheology 1979 16 231 248 508933
180. Flow patterns in the dog descending aorta under a steady flow condition stimulating mid-systole. S Endo T Karino HL Goldsmith, JSME International Journal, Series C 2004 47 1000 1009 10.1299/jsmec.47.1000
181. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. T Asakura T Karino, Circ Res 1990 66 1045 1066 2317887
182. Intimal hyperplasia, vascular modeling, and the restenosis problem. S Glagov, Circulation 1994 89 2888 2891 8205705
183. Adaptive regulation of wall shear stress optimizing vascular tree function. A Kamiya R Bukhari T Togawa, Bull Math Biol 1984 46 127 137 6713148
184. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. A Kamiya T Togawa, Am J Physiol 1980 239 H14 21 7396013
185. Event Flow. Shear Stress Cues Vascular Development. Editorial. C Patterson, Arterioscler Thromb Vasc Biol 2005 25 1761 1762 10.1161/01.ATV. 0000175755.93591.56 16127024
186. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. H Wang GM Riha S Yan M Li H Chai H Yang Q Yao C Chen, Arterioscler Thromb Vasc Biol 2005 25 1817 1823 10.1161/01.ATV. 0000175840.90510.a8 15994439
187. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. K Yamamoto T Sokabe T Watabe K Miyazono JK Yamashita S Obi N Ohura A Matsushita A Kamiya J Ando, Am J Physiol Heart Circ Physiol 2005 288 H1915 1924 10.1152/ajpheart.00956.2004 15576436
188. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. K Yamamoto T Takahashi T Asahara N Ohura T Sokabe A Kamiya J Ando, J Appl Physiol 2003 95 2081 2088 12857765
189. Development of our Knowledge of Arteriosclerosis. ER Long, Cowdry's arteriosclerosis; a survey of the problem Springfield, Ill.: Thomas, Blumenthal HT, 2 1967 5 20
190. Phlogose und Thrombose in Gefägermanbsystem. R Virchow, Gesammelte Abhandlungen zur Wissenschaftlichen Medicin Frankfurt: Von Medinger Sohn, Virchow R, 1856 458 636
191. TS Kuhn, The Structure of Scientific Revolutions Chicago: University of Chicago Press 1962
192. Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia. JJ Kastelein SI van Leuven L Burgess GW Evans JA Kuivenhoven PJ Barter JH Revkin DE Grobbee WA Riley CL Shear, N Engl J Med 2007 356 16 1620 30 10.1056/NEJMoa071359 17387131
193. Effect of torcetrapib on the progression of coronary atherosclerosis. SE Nissen JC Tardif SJ Nicholls JH Revkin CL Shear WT Duggan W Ruzyllo WB Bachinsky GP Lasala EM Tuzcu, N Engl J Med 2007 356 1304 1316 10.1056/NEJMoa070635 17387129
194. CETP Inhibitors to Increase HDL Cholesterol Levels. AR Tall, N Engl J Med 2007 356 17387130
195. Coronary heart disease, hypercholesterolemia, and atherosclerosis. I. False premises. WE Stehbens, Exp Mol Pathol 2001 70 103 119 10.1006/exmp.2000. 2340 11263954
196. Coronary heart disease, hypercholesterolemia, and atherosclerosis. II. Misrepresented data. WE Stehbens, Exp Mol Pathol 2001 70 120 139 10.1006/exmp.2000.2339 11263955
197. The hypothetical epidemic of coronary heart disease and atherosclerosis. WE Stehbens, Med Hypotheses 1995 45 449 454 10.1016/0306-9877(95)90219-8 8748084
198. The idea is more important than the experiment. J Martin, Lancet 2000 356 934 937 10.1016/S0140-6736(00)02691-X 11036911
199. AS Romer, The vertebrate body Philadelphia: Saunders College Pub 6 1986
200. Comparative anatomy and ontogeny of the ductus arteriosus, a vascular outsider. M Bergwerff MC DeRuiter AC Gittenberger-de Groot, Anat Embryol (Berl) 1999 200 559 571 10.1007/s004290050304 10592060
201. Histomorphologic and morphometric evaluation of the uterine horns in nulliparous and multiparous Beagles. HR Augsburger M Kurzi, Am J Vet Res 2004 65 552 558 10.2460/ajvr.2004.65.552 15141872
202. Modification of uterine vasculature during pregnancy in macaques. TN Blankenship AC Enders, Microsc Res Tech 2003 60 390 401 10.1002/jemt.10277 12567396
203. Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide. S Obayashi T Aso J Sato H Hamasaki H Azuma, Br J Pharmacol 1996 119 1072 1078 8922760
204. Hypertrophic and hyperplastic effects of pregnancy on the rat uterine arterial wall. M Cipolla G Osol, Am J Obstet Gynecol 1994 171 805 811 8092233
205. Effect of pregnancy on gravid sclerosis of bovine uterine arteries. S Kamiya M Daigo, Nippon Juigaku Zasshi 1989 51 1179 1184 2601230
206. Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries. M Beppu S Obayashi T Aso M Goto H Azuma, J Cardiovasc Pharmacol 2002 39 192 200 10.1097/00005344-200202000-00005 11791004
207. Uterine artery atherosclerotic disease: histologic features and clinical correlation. BS Crawford J Davis K Harrigill, Obstet Gynecol 1997 90 210 215 10.1016/S0029-7844(97)00225-1 9241295
208. Electron microscopic and histochemical characterization of intra-arterial cushions of the rat and porcine uterine vascular bed. PM Heidger Jr DE Van Orden DB Farley, Acta Anat (Basel) 1983 117 239 247 6650119
209. Intraarterial cushions of the rat uterine artery: a scanning electron microscope evaluation utilizing vascular casts. RH Kardon DB Farley PM Heidger Jr DE Van Orden, Anat Rec 1982 203 19 29 10.1002/ar.1092030103 7049004
210. Contributions to the study of the foetal development of physiological intimal thickening in the human uterine artery. JO Whyte AI Cisneros M Alvarez MD Alconchel C Yus A Torres R Sarrat, Folia Morphol (Warsz) 2001 60 199 204 11552660
211. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries. RY Loyaga-Rendon S Sakamoto M Beppu T Aso M Ishizaka R Takahashi H Azuma, Atherosclerosis 2005 178 231 239 10.1016/j.atherosclerosis.2004.09.006 15694929
212. Molecular mechanisms in intimal hyperplasia. AC Newby AB Zaltsman, J Pathol 2000 190 300 309 10.1002/(SICI)1096-9896(200002)190:3<300::AID- PATH596>3.0.CO;2-I 10685064
213. Ultrastructure of human umbilical arteries. Studies on arteries from newborn children delivered by nonsmoking, white group D, diabetic mothers. I Asmussen, Circ Res 1980 47 620 626 7408138
214. Ultrastructure of aging human umbilical artery and vein. T Takagi T Toda D Leszczynski F Kummerow, Acta Anat (Basel) 1984 119 73 79 6730900
215. Histopathology and ultrastructure of human umbilical blood vessels. WE Stehbens JS Wakefield E Gilbert-Barness JM Zuccollo, Fetal Pediatr Pathol 2005 24 297 315 10.1080/15227950500503660 16761560
216. Increasing peripheral artery intima thickness from childhood to seniority. W Osika F Dangardt J Gronros U Lundstam A Myredal M Johansson R Volkmann T Gustavsson LM Gan P Friberg, Arterioscler Thromb Vasc Biol 2007 27 671 676 10.1161/01.ATV.0000256468.95403.6f 17194890
217. Comparative morphology of intimal and adventitial hyperplasia of the arteriosclerotic turkey aorta. CF Simpson, Exp Mol Pathol 1972 17 65 76 10.1016/0014-4800(72)90058-5 5043335
218. Naturally occuring arteriosclerosis in animals: a comparison with experimentally induced lesions. S Lindsay IL Chaikoff, Atherosclerosis and its origin New York: Academic Press, Sandler M, Bourne GH, 1963 349 437
219. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery. R Friedl J Li B Schumacher H Hanke J Waltenberger A Hannekum S Stracke, Ann Thorac Surg 2004 78 1312 1318 10.1016/j.athoracsur.2004.02.066 15464491
220. Intimal hyperplasia of the infant parasellar carotid artery: a potential developmental factor in atherosclerosis and SIDS. WJ Weninger GB Muller C Reiter S Meng SU Rabl, Circ Res 1999 85 970 975 10559145
221. Localised coarctation of the aorta. An age dependent spectrum. NJ Elzenga AC Gittenberger-de Groot, Br Heart J 1983 49 317 323 6830664 10.1136/hrt.49.4.317
222. Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life. CE Head VC Jowett GK Sharland JM Simpson, Heart 2005 91 1070 1074 10.1136/hrt.2003.033027 16020599
223. Histological findings after angioplasty using conventional balloon, radiofrequency thermal balloon, and stent for experimental aortic coarctation. M Ohkubo K Takahashi M Kishiro K Akimoto Y Yamashiro, Pediatr Int 2004 46 39 47 10.1111/j.1328-0867.2004.t01-1-.x 15043663
224. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. A Navas-Acien E Selvin AR Sharrett E Calderon-Aranda E Silbergeld E Guallar, Circulation 2004 109 3196 3201 10.1161/01.CIR.0000130848.18636.B2 15184277
225. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. PM Ridker MJ Stampfer N Rifai, Jama 2001 285 2481 2485 10.1001/jama.285.19.2481 11368701
226. Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease. S Inoue H Koyama T Miyata H Shigematsu, J Vasc Surg 2002 35 672 678 10.1067/mva.2002.122021 11932661
227. Local endovascular delivery, gene therapy, and cell transplantation for peripheral arterial disease. SR Opie N Dib, J Endovasc Ther 2004 11 Suppl 2 II151 162 15760251
228. Peripheral vascular brachytherapy. AN Sidawy JM Weiswasser R Waksman, J Vasc Surg 2002 35 1041 1047 10.1067/mva.2002.123751 12021726
229. Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. MS Cappell, Gastroenterol Clin North Am 1998 27 827 860 10.1016/S0889-8553(05)70034-0 9890115
230. Intimal thickening and fragmentation of the internal elastic lamina in the mesenteric arteries. O Jarvinen T Sisto J Laurikka M Tarkka, Apmis 1996 104 395 400 8703447
231. Diffuse intimal fibromuscular dysplasia with multiorgan failure. JB Stokes SM Bonsib JW McBride, Arch Intern Med 1996 156 2611 2614 10.1001/archinte.156.22.2611 8951305
232. Von Recklinghausen's vasculopathy. D Zochodne, Am J Med Sci 1984 287 64 65 10.1097/00000441-198401000-00021 6422759
233. Improvement of patency rate in heparin-coated small synthetic vascular grafts. BH Walpoth R Rogulenko E Tikhvinskaia S Gogolewski T Schaffner OM Hess U Althaus, Circulation 1998 98 II319 323 discussion II324 9852921
234. Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. BH Walpoth M Pavlicek B Celik B Nicolaus T Schaffner U Althaus OM Hess T Carrel RE Morris, Eur J Cardiothorac Surg 2001 19 487 492 10.1016/S1010-7940(01)00582-6 11306318
235. Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: the failure of low-density seeding to improve patency. M Herring J Smith M Dalsing J Glover R Compton K Etchberger T Zollinger, J Vasc Surg 1994 20 650 655 7933268
236. Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up. N Jensen B Lindblad D Bergqvist, J Cardiovasc Surg (Torino) 1994 35 425 429 7995835
237. Release of PDGF-BB and bFGF by human endothelial cells seeded on expanded polytetrafluoroethylene vascular grafts. P Sapienza L di Marzo A Cucina V Corvino A Mingoli Q Giustiniani E Ziparo A Cavallaro, J Surg Res 1998 75 24 29 10.1006/jsre.1997.5260 9614852
238. Evaluation of expanded polytetrafluoroethylene arteriovenous access grafts onto which microvessel-derived cells were transplanted to "improve" graft performance: preliminary results. SP Schmidt SO Meerbaum JM Anderson RE Clarke RA Zellers WV Sharp, Ann Vasc Surg 1998 12 405 411 10.1007/s100169900176 9732416
239. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. A Kumar V Lindner, Arterioscler Thromb Vasc Biol 1997 17 2238 2244 9351395
240. Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases. HS Ahn S Chackalamannil G Boykow MP Graziano C Foster, Curr Pharm Des 2003 9 2349 2365 10.2174/1381612033453884 14529396
241. Inflammation and restenosis: implications for therapy. MM Donners MJ Daemen KB Cleutjens S Heeneman, Ann Med 2003 35 523 531 10.1080/ 07853890310014876 14649334
242. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. GA Ferns EW Raines KH Sprugel AS Motani MA Reidy R Ross, Science 1991 253 1129 1132 10.1126/science.1653454 1653454
243. Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. S Kitamoto K Egashira A Takeshita, J Pharmacol Sci 2003 91 192 196 10.1254/jphs.91.192 12686741
244. Atherosclerosis - an inflammatory disease. R Ross, N Engl J Med 1999 340 115 126 10.1056/NEJM199901143400207 9887164
245. Restenosis after percutaneous angioplasty: the role of vascular inflammation. M Schillinger E Minar, Vasc Health Risk Manag 2005 1 73 78 10.2147/vhrm.1.1.73.58932 17319099
246. Prevention of restenosis after stenting: the emerging role of inflammation. F Versaci A Gaspardone, Coron Artery Dis 2004 15 307 311 10.1097/00019501-200409000-00002 15346087
247. High sensitive C-reactive protein and interleukin 6 are not related to neointimal hyperplasia in paclitaxel eluting stents or bare metal stents. An intravascular ultrasound study. J Klitkou LO Jensen HS Hansen P Thayssen, Int J Cardiol 2007 119 114 116 10.1016/j.ijcard.2006.07.073 17069905
248. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. S Sartore A Chiavegato E Faggin R Franch M Puato S Ausoni P Pauletto, Circ Res 2001 89 1111 1121 10.1161/hh2401.100844 11739275
249. Intimal thickening involves transdifferentiation of embryonic endothelial cells. E Arciniegas L Ponce Y Hartt A Graterol RG Carlini, Anat Rec 2000 258 47 57 10.1002/(SICI)1097-0185(20000101)258:1<47::AID-AR6>3.0.CO;2-W 10603448
250. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. D Skowasch A Jabs R Andrie S Dinkelbach B Luderitz G Bauriedel, Cardiovasc Res 2003 60 684 691 10.1016/j.cardiores.2003.09.001 14659814
251. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. P Carmeliet L Moons JM Stassen M De Mol A Bouche JJ van den Oord M Kockx D Collen, Am J Pathol 1997 150 761 776 9033288
252. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. V Subbotin H Sun A Aitouche A Salam LA Valdivia JJ Fung TE Starzl AS Rao, Transplantation 1999 67 1295 1300 10.1097/00007890-199905270-00001 10360580
253. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. V Subbotin H Sun A Aitouche LA Valdivia JJ Fung TE Starzl AS Rao, Transplantation 1997 64 690 695 10.1097/00007890-199709150-00005 9311704
254. Cope's rule and the dynamics of body mass evolution in North American fossil mammals. J Alroy, Science 1998 280 731 734 10.1126/science.280.5364.731 9563948
255. Cope's rule, the island rule and the scaling of mammalian population density. J Damuth, Nature 1993 365 748 750 10.1038/365748a0 8413651
256. Relationship between socio-demographic and behaviour variables, and body mass index in a population with high-normal blood pressure: Hypertension Prevention Trial. M Shah RW Jeffery PJ Hannan L Onstad, Eur J Clin Nutr 1989 43 583 596 2606089
257. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. V Nuzzo L Tauchmanova F Fonderico R Trotta MR Fittipaldi D Fontana R Rossi G Lombardi B Trimarco G Lupoli, Eur J Endocrinol 2002 147 453 459 10.1530/eje.0.1470453 12370105
258. What is normal blood pressure? MH Freitag RS Vasan, Curr Opin Nephrol Hypertens 2003 12 285 292 10.1097/00041552-200305000-00010 12698067
259. A patient with high normal blood pressure - Should we treat? D Czarnecka G Bilo, Blood Press 2005 14 Suppl 2 50 52 10.1080/08038020500424715 16428173
260. The development of preatherosclerotic coronary artery lesions in perinatal piglets. RP Bolande EA Leistikow FS Wartman 3rd TM Louis, Biol Neonate 1996 69 109 118 8713656
261. Anatomic Considerations for Regional Intimal Changes in the Coronary Arteries (Dog). RJ Boucek R Fojaco R Takashita, Anat Rec 1964 148 161 169 10.1002/ar.1091480206 14123500
262. Age-related changes in non-enzymatic glycosylation of human basement membranes. MP Cohen V Yu-Wu, Exp Gerontol 1983 18 461 469 10.1016/0531-5565(83) 90025-6 6425073
263. The aortic tunica intima in young and aging rats. RG Gerrity WJ Cliff, Exp Mol Pathol 1972 16 382 402 10.1016/0014-4800(72)90012-3 4337757
264. Comparative morphology of the hepatic and coronary artery walls. Part II. The relation between the internal elastic membrane, non- atherosclerotic intimal thickening and atherosclerosis. S Krus MW Turjman E Flejka, Med Sci Monit 2000 6 249 252 11208318
265. Fine structure of "intimal cushions" at branching sites in coronary arteries of vertebrates. A scanning and transmission electron microscopic study. T Yoro G Burnstock, Z Anat Entwicklungsgesch 1973 140 187 202 10.1007/BF00520330 4748697
266. Ultrastructure of endothelial cells under flow alteration. H Masuda K Kawamura H Nanjo E Sho M Komatsu T Sugiyama A Sugita Y Asari M Kobayashi T Ebina, Microsc Res Tech 2003 60 2 12 10.1002/jemt.10237 12500255
267. Intermittent short-duration exposure to low wall shear stress induces intimal thickening in arteries exposed to chronic high shear stress. H Nanjo E Sho M Komatsu M Sho CK Zarins H Masuda, Exp Mol Pathol 2006 80 38 45 15961075
268. Difference in dilatation between endothelium-preserved and -desquamated segments in the flow-loaded rat common carotid artery. K Tohda H Masuda K Kawamura T Shozawa, Arterioscler Thromb 1992 12 519 528 1558839
269. Flow patterns and preferred sites of intimal thickening in diameter-mismatched vein graft interpositions. M Sunamura H Ishibashi T Karino, Surgery 2007 141 764 776 10.1016/j.surg.2006.12.019 17560253
270. Pulsatile flow visualization in the abdominal aorta under differing physiologic conditions: implications for increased susceptibility to atherosclerosis. JE Moore Jr DN Ku CK Zarins S Glagov, J Biomech Eng 1992 114 391 397 1295493
271. Cardiovascular effects of exercise: role of endothelial shear stress. J Niebauer JP Cooke, J Am Coll Cardiol 1996 28 1652 1660 10.1016/S0735-1097(96) 00393-2 8962548
272. Heterogeneity of antigen expression among human umbilical cord vascular endothelial cells: identification of cell subsets by co-expression of haemopoietic antigens. C Vermot-Desroches D Marchand C Roy J Wijdenes, Immunol Lett 1995 48 1 9 10.1016/0165-2478(95)02432-8 8847083
273. Induction of embryonic hematopoietic and endothelial stem/progenitor cells by hedgehog-mediated signals. M Baron, Differentiation 2001 68 175 185 10.1046/j.1432-0436.2001.680405.x 11776470
274. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. MC Dickson JS Martin FM Cousins AB Kulkarni S Karlsson RJ Akhurst, Development 1995 121 1845 1854 7600998
275. Florence Sabin and the mechanism of blood vessel lumenization during vasculogenesis. KM Downs, Microcirculation 2003 10 5 25 12610661
276. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. M Sanchez B Gottgens AM Sinclair M Stanley CG Begley S Hunter AR Green, Development 1999 126 3891 3904 10433917
277. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. HB Wood G May L Healy T Enver GM Morriss-Kay, Blood 1997 90 2300 2311 9310481
278. Unique vascular morphology of the fourth aortic arches: possible implications for pathogenesis of type-B aortic arch interruption and anomalous right subclavian artery. M Bergwerff MC DeRuiter S Hall RE Poelmann AC Gittenberger-de Groot, Cardiovasc Res 1999 44 185 196 10.1016/S0008-6363(99) 00186-8 10615402
279. Heart development: molecular insights into cardiac specification and early morphogenesis. T Brand, Dev Biol 2003 258 1 19 10.1016/S0012-1606(03) 00112-X 12781678
280. Importance of the basement membrane protein SPARC for viability and fertility in Caenorhabditis elegans. MC Fitzgerald JE Schwarzbauer, Curr Biol 1998 8 1285 1288 10.1016/S0960-9822(07)00540-4 9822581
281. Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. VM Paralkar S Vukicevic AH Reddi, Dev Biol 1991 143 303 308 10.1016/0012-1606(91)90081-D 1991553
282. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. WC Aird, Circ Res 2007 100 158 173 10.1161/01.RES.0000255691.76142. 4a 17272818
283. Shear stress and the endothelium. BJ Ballermann A Dardik E Eng A Liu, Kidney Int Suppl 1998 67 S100 108 10.1046/j.1523-1755.1998.06720.x 9736263
284. Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3. T Gloe HY Sohn GA Meininger U Pohl, J Biol Chem 2002 277 23453 23458 10.1074/jbc.M203889200 11976347
285. AO: : ; 1951
286. Archetypal organization of the amphioxus Hox gene cluster. J Garcia-Fernandez PW Holland, Nature 1994 370 563 566 10.1038/370563a0 7914353
287. Nothing in Biology Makes Sense Except in the Light of Evolution. T Dobzhansky, The American Biology Teacher 1973 35 125 129 http://people. delphiforums.com/lordorman/light.htm
288. Divergent evolution, hierarchy and cladistics. MSY Lee, Zoologica Scripta 2002 31 217 219 10.1046/j.1463-6409.2002.00101.x
289. TL Brown, Making Truth. The Roles of Metaphor in Science Urbana: University of Illinois Press 2003
290. Therapeutics of vein graft intimal hyperplasia: 100 years on. EJ Wallitt M Jevon PI Hornick, Ann Thorac Surg 2007 84 317 323 10.1016/j.athoracsur.2007. 02.035 17588453
291. Basilar artery of the capybara (Hydrochaeris hydrochaeris): an ultrastructural study. S Islam AA Ribeiro A Loesch, Anat Histol Embryol 2004 33 81 89 10.1111/j.1439-0264.2003.00519.x 15027948